CRBP
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ · Healthcare
Corbus Pharmaceuticals Holdings, Inc. annual/quarterly revenue history and growth rate from 2015 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Corbus Pharmaceuticals Holdings, Inc. revenue for the quarter ending September 30, 2022 was 0, a 100.00% decrease year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. revenue for the twelve months ending September 30, 2022 was 233881, a 94.04% decrease year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. annual revenue for 2022 was 0, a 100.00% decrease from 2021.
- Corbus Pharmaceuticals Holdings, Inc. annual revenue for 2021 was 881705, a 77.61% decrease from 2020.
- Corbus Pharmaceuticals Holdings, Inc. annual revenue for 2020 was 3.9 M, a 89.11% decrease from 2019.
- Corbus Pharmaceuticals Holdings, Inc. annual revenue for 2019 was 36.1 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Corbus Pharmaceuticals Holdings, Inc. Earnings — FAQ
Corbus Pharmaceuticals Holdings, Inc. (CRBP) earnings over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRBP's earnings history?
The chart and table above show Corbus Pharmaceuticals Holdings, Inc.'s earnings by year and by quarter, including the growth rate.